GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

Shanghai MicroPort MedBot Group Co 2252.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥551.1m

FY2019FY2025

Net income

−CN¥249.7m

FY2019FY2025

Free cash flow

−CN¥38.8m

FY2019FY2025

Shareholders' equity

CN¥410.8m

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
RevenueCN¥551.1mCN¥218.2mCN¥88.7mCN¥21.6mCN¥2.1m——
Research and developmentCN¥216.0mCN¥261.9mCN¥482.8mCN¥755.8mCN¥392.6mCN¥135.4mCN¥61.9m
Operating income−CN¥235.3m−CN¥414.6m−CN¥827.1m−CN¥1.10bn−CN¥551.7m−CN¥158.4m−CN¥69.3m
Net income−CN¥249.7m−CN¥544.9m−CN¥858.5m−CN¥1.14bn−CN¥582.9m−CN¥208.9m−CN¥70.3m
Diluted earnings per share-0.24-0.56-0.90-1.19-0.63-0.26-0.07

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsCN¥1.34bnCN¥1.28bnCN¥1.43bnCN¥1.93bnCN¥2.79bnCN¥1.70bnCN¥78.4m
Cash and short-term investmentsCN¥640.4mCN¥612.2mCN¥507.7mCN¥748.0mCN¥1.94bnCN¥1.50bnCN¥54.7m
Total liabilitiesCN¥935.1mCN¥1.02bnCN¥926.2mCN¥522.2mCN¥401.7mCN¥262.9mCN¥52.0m
DebtCN¥426.4mCN¥691.3mCN¥560.4mCN¥219.9mCN¥204.7mCN¥19.2mCN¥11.9m
Shareholders' equityCN¥410.8mCN¥278.2mCN¥519.5mCN¥1.42bnCN¥2.39bnCN¥1.44bnCN¥26.4m
Shares outstanding1,031m975m959m959m930m806m1,031m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−CN¥36.3m−CN¥252.9m−CN¥567.8m−CN¥898.5m−CN¥540.5m−CN¥103.0m−CN¥48.7m
Capital spending−CN¥2.5m−CN¥35.7m−CN¥66.5m−CN¥194.8m−CN¥134.0m−CN¥15.0m−CN¥3.7m
Free cash flow−CN¥38.8m−CN¥288.6m−CN¥634.3m−CN¥1.09bn−CN¥674.5m−CN¥118.1m−CN¥52.4m

Latest quarters

By quarter end

Dec 2025Jun 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023
RevenueCN¥375.4mCN¥175.7mCN¥134.0mCN¥79.0mCN¥84.2mCN¥49.6mCN¥48.3mCN¥28.5m
Operating income−CN¥124.5m−CN¥110.8m−CN¥207.1m−CN¥122.1m−CN¥207.5m−CN¥122.3m−CN¥370.0m−CN¥208.3m
Net income−CN¥136.3m−CN¥113.4m−CN¥309.8m−CN¥182.6m−CN¥235.1m−CN¥138.6m−CN¥401.3m−CN¥236.6m
Diluted earnings per share-0.13-0.11-0.32-0.19-0.24-0.14-0.42-0.25
Cash from operationsCN¥82.0m−CN¥113.0m−CN¥91.0m—−CN¥206.0m−CN¥103.0m−CN¥170.0m−CN¥85.0m
Capital spending−CN¥1.0m−CN¥1.0m−CN¥26.0m—−CN¥15.0m−CN¥7.0m−CN¥23.0m−CN¥11.0m
Free cash flowCN¥81.0m−CN¥114.0m−CN¥117.0m—−CN¥221.0m−CN¥110.0m−CN¥193.0m−CN¥96.0m
Total assetsCN¥1.34bnCN¥1.50bnCN¥1.08bnCN¥1.28bnCN¥952.5mCN¥1.12bnCN¥1.21bnCN¥1.43bn
Cash and short-term investmentsCN¥640.4mCN¥815.8mCN¥519.3mCN¥612.2mCN¥187.5mCN¥221.1mCN¥430.6mCN¥507.7m
DebtCN¥410.6mCN¥668.2mCN¥586.4mCN¥279.7mCN¥458.9mCN¥242.7mCN¥505.4mCN¥423.6m
Shareholders' equityCN¥410.8mCN¥535.1mCN¥236.0mCN¥278.2mCN¥233.2mCN¥274.9mCN¥440.6mCN¥519.5m

Financial ratios

Data as of 23 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-43.8%-184.4%-932.3%-5086.3%-25660.2%—
Net margin-45.3%-249.7%-967.7%-5276.1%-27112.6%—
Return on equity-60.8%-230.9%-194.8%-80.4%-24.4%-14.5%
Return on assets-18.7%-50.2%-70.9%-59.1%-20.9%-12.3%
Free cash flow yield-0.2%-1.2%-2.5%-3.5%-2.1%-0.5%
Revenue growth114.2%146.0%384.2%904.8%——
Earnings growth-61.1%-36.5%-11.2%95.5%179.1%197.0%
Current ratio2.30x1.70x1.16x3.38x8.93x6.62x
Debt to equity0.99x2.40x1.01x0.06x0.02x0.01x
Equity ratio30.8%21.8%36.4%73.4%85.7%84.7%
Interest coverage-12.26x-22.06x-52.97x-98.76x-104.23x-4.10x
R&D as a share of sales39.2%120.0%544.2%3498.6%18262.7%—
Buybacks as a share of market value-5.8%-1.7%0.0%-3.0%-15.4%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue194.4%——
Operating income-40.2%8.2%—
Net income-39.7%3.6%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-84.5%-292.8%——
Net margin-103.3%-317.5%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-86.7-14.8-20.2-23.2-80.9
Price to sales39.336.9195.1——

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.